Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson’s Disease by Fauser, Mareike et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.3233/JPD-150656
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Fauser, M., Löhle, M., Ebersbach, G., Odin, P., Fuchs, G., Jost, W. H., ... Storch, A. (2015). Intraindividual
Variability of Nonmotor Fluctuations in Advanced Parkinson’s Disease. Journal of Parkinson's disease, 5, 737-
741. DOI: 10.3233/JPD-150656
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
AU
TH
OR
 C
OP
Y
Journal of Parkinson’s Disease 5 (2015) 737–741
DOI 10.3233/JPD-150656
IOS Press
737
Short Communication
Intraindividual Variability of Nonmotor
Fluctuations in Advanced Parkinson’s
Disease
Mareike Fausera, Matthias Lo¨hlea,b, Georg Ebersbachc, Per Odind,e, Gerd Fuchsf , Wolfgang H. Jostf ,
K. Ray Chaudhurig, Rainer Kochh, NoMoFlu-PD study group and Alexander Storcha,b,i,∗
aDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universita¨t Dresden,
Dresden, Germany
bDepartment of Neurology, University of Rostock, Rostock, Germany
cMovement Disorders Clinic, Beelitz-Heilsta¨tten, Germany
dDepartment of Neurology, Klinikum Bremerhaven, Bremerhaven, Germany
eDepartment of Neurology, University Hospital, Lund, Sweden
fParkinson Clinic Wolfach, Wolfach, Germany
gNational Parkinson Foundation Centre of Excellence, Kings College Hospital and Kings College London and
Biomedical Research Centre, Kings College London, UK
hDepartment of Medical Informatics and Biometry, Technische Universita¨t Dresden, Dresden, Germany
iGerman Center for Neurodegenerative Diseases (DZNE), Rostock, Germany
Abstract. Nonmotor symptoms (NMS) fluctuate in conjunction with motor oscillations in advanced Parkinson’s disease (PD),
though little is known about the variability of NMS fluctuations in individual patients. We aimed to assess within-patient
variability in frequency and severity of NMS during a series of five patient-perceived motor On and Off periods in 38 fluctuating
PD patients from the multicenter NonMotorFluctuations in PD study using a visual analogue scale. NMS frequency and severity
appeared moderately variable in both motor states within individual patients. Symptom severity ranges between motor states
showed high variability and were larger in motor Off states for most NMS.
Keywords: Nonmotor symptoms, nonmotor fluctuations, intraindividual variability, Parkinson’s disease, NMS domains
INTRODUCTION
Nonmotor symptoms (NMS) are reported in the
majority of Parkinson’s disease (PD) patients and have
strong impact on health-related quality of life (hr-QoL)
[1]. Fluctuations of NMS can occur with oscillations
∗Correspondence to: Alexander Storch, M.D., Department of
Neurology, University of Rostock, Gehlsheimer Strasse 20, 18147
Rostock, Germany. Tel.: +49 381 494 9510; Fax: +49 381 494 9512;
E-mail: alexander.storch@med.uni-rostock.de.
in response to dopaminergic medication [2–4] and
are present in up to 100% of fluctuating PD patients
[3, 5]. This study complements preceding reports
of the NonMotor Fluctuations in PD (NoMoFlu-PD)
study, a multicenter cross-sectional study to assess
NMS fluctuations (NMF) and their correlation with
motor fluctuations and hr-QoL [6, 7], which used
semi-structured interviews in combination with visual
analogue scales (VAS) and VAS-based home diaries
to characterize NMF in relation to motor states. We
ISSN 1877-7171/15/$35.00 © 2015 – IOS Press and the authors. All rights reserved
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found complex heterogeneous patterns of NMFs with
particularly frequent and severe fluctuations in psychi-
atric NMS compared to other NMS domains [6, 7].
However, it remains unclear whether and how NMF
vary in an individual subject. The repeated evaluation
of ten key NMS over five motor On and five Off peri-
ods reported in this manuscript allowed us to estimate
the intraindividual (within-patient) stability of NMF.
The present analyses thus aim to investigate intrain-
dividual NMS variability of symptom frequency and
severity between multiple motor On/Off states based
on repeated home diary assessments in fluctuating PD.
SUBJECTS AND METHODS
The study population and assessments have been
described elsewhere [6]. In brief, PD patients of
all ages and disease severities were included in the
NoMoFlu-PD study, if they experienced documented
motor fluctuations and in addition did not show any
signs of atypical parkinsonism, psychosis, demen-
tia or other relevant conditions interfering with the
study protocol. Subjects rated a total of ten NMS
(Table 1) during five self-perceived motor On and Off
states at home as “present” or “absent” and subse-
quently the NMS severity using a visual analogue scale
(VAS) with a symptom range from 0 (not present) to
100 (maximum symptom intensity). During the ini-
tial study visit, patients were trained in how to use
a visual analogue scale and their diaries. In addi-
tion, the study visit included a levodopa challenge
test, so patients were asked to arrive in the outpa-
tient clinic after a 12 hour medication withdrawal [6].
During the visit, patients experienced both a defined
motor On and Off state and were asked to complete
their home diaries while experiencing similar motor
states.
Statistical comparisons between motor states and
NMS intensity ranges or patterns, respectively, were
calculated using Wilcoxon rank test, McNemar test,
Student´s paired and unpaired t-test, χ2, Fisher’s exact
test, and Friedman non-parametric repeated-measure
ANOVA as appropriate. In addition, we calculated
Mahalanobis distances (MD), a measure of the distance
between individual patients´ NMS severity ranges and
mean NMS ranges across all the NMS. If not stated
otherwise, data are displayed as mean ± standard
deviation (SD), absolute numbers or numbers (%).
Two-tailed P < 0.05 were deemed statistically signif-
icant. Due to the explorative character of the study, 
adjustment of P-values has not been carried out.
RESULTS
Demographic characteristics of the overall
NoMoFlu-PD study cohort have been reported
previously [6]. Complete home diary datasets were
available from 38 (38%) patients (24 men (63%);
mean age ± SD: 65.6 ± 8.2 years; disease dura-
tion: 10.3 ± 7.0 years; Hoehn and Yahr stage in
On: 2.4 ± 0.9 and Off state: 3.1 ± 1.0; P < 0.0001
[Wilcoxon test]; UPDRSIII motor score in On:
15.3 ± 11.9 and Off: 31.1 ± 12.0; P < 0.0001 [paired
t-test]). Patients with complete home diary datasets
had younger age, shorter disease duration and milder
PD symptoms compared to patients without complete
home diary data (see Supplementary Table 1 for
complete statistics). All subsequent analyses were
performed for the former patient cohort in order
to prevent bias due to skewed adherence to diary
records. Most of the diaries were completed in the
morning hours before 12:00 am for both motor states
(medians [maximal interquartile ranges]: 9:30 to
11:30 [8:30–14:30] for the five On and 8:30 to 11:30
[7:00–16:00] for the five Off states) with no significant
differences between the various motor states (P > 0.05;
Friedman ANOVA).
For the assessment of intraindividual variability of
NMF, diary data were dichotomized to assign patients
to one of two groups within each motor state: “instable”
fluctuating patients reported a respective NMS within
1–4 of 5 assessments of a given motor state, whilst “sta-
ble” fluctuating subjects presented with a specific NMS
during either all or none of the investigated motor state.
The percentage of instable fluctuating PD patients
was used to assess NMS recurrence in the respec-
tive motor state (Table 1). We found a significantly
higher proportion of instable NMS fluctuators within
motor Off states solely for depression (P = 0.007), anx-
iety (P = 0.031) and bladder urgency (P = 0.0.049). All
other NMS did not differ significantly between motor
states. We did not detect any differences of demo-
graphic and clinical characteristics between stable and
instable NMS fluctuators.
To further characterize NMS presentation in individ-
ual patients, we analyzed NMF patterns within both
motor states. Patterns were defined according to the
number of presentation of individual NMS over the
total of five motor states ranging from 0/5 (symp-
tom absent in all five assessments) to 5/5 (symptom
present in all five explorations). All NMS except prob-
lems with concentration/attention, bladder urgency,
excessive sweating and dysphagia demonstrated a sig-
nificantly different distribution of NMF between the
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two motor states with a shift towards a more insta-
ble and more frequent occurrence of NMS in motor
Off state compared to motor On state (Supplementary
Table 2).
Next, we assessed the variability of severities of
these ten NMS between different On states and dif-
ferent Off states on the individual subject level. We
therefore used the range of home diary VAS scores
from a total of five self-perceived motor On as well
as Off states in each individual as a measure of
motor symptoms and NMS severity variability with
higher ranges representing higher variability (Table 2).
Although the motor function was rated worse in Off
compared to On state (63 ± 17% versus 39 ± 22%
on VAS, P < 0.001, Wilcoxon test) [6], the intraindi-
vidual variability of motor dysfunction between the
motor On and Off states did not show significant
differences. Except for dysphagia, all NMS demon-
strated a significantly higher intraindividual variability
(higher ranges) in symptom severity during motor Off
states. Using the Mahalanobis distance (MD) as a
multidimensional measure of data distribution of all
NMS severity ranges within each individual subject,
we found that intraindividual NMS severity ranges
were not significantly different between motor On and
Off states (P = 0.392). Similar results were obtained
for both motor states when using only morning rat-
ings from before 12:00 am (not shown). Normalization
of NMS severity to motor function of the respective
motor state led to increased intraindividual severity
variability of all NMS on both motor states (Sup-
plementary Table 3). We did not detect differences
between the patients with complete and incomplete
diary.
Table 1
Instability of nonmotor symptoms during a series of motor On and Off states
Nonmotor domain Nonmotor symptom Instable NMS fluctuationsa P valueb
(% of motor fluctuating subjects)
Motor On state Motor Off state
Psychiatric NMS Depression 6 (15.8%) 17 (44.7%) 0.007
Anxiety 8 (21.1%) 18 (47.3%) 0.031
Concentration/attention 10 (26.3%) 12 (31.6%) 0.791
Fatigue 20 (52.6%) 14 (36.8%) 0.238
Autonomic NMS Bladder urgency 9 (23.7%) 18 (47.4%) 0.049
Excessive sweating 11 (28.9%) 14 (36.8%) 0.629
Dizziness 11 (28.9%) 10 (26.3%) 1.000
Sensory NMS Pain 14 (36.8%) 9 (23.7%) 0.267
Miscellaneous Dysphagia 5 (13.2%) 13 (34.2%) 0.057
Inner restlessness 11 (28.9%) 15 (39.5%) 0.344
aInstable patients are defined as fluctuating patients reporting a respective NMS within 1–4 of 5 assessments of a given motor state. bP values
are from McNemar test.
Table 2
Intraindividual variability of motor and nonmotor symptom severities between different motor On and different Off statesa
Motor function/ Nonmotor symptom Motor On state Motor Off state P valueb
NMS domain Mean ± SD Median Min-Max Mean ± SD Median Min-Max
range range range range
Motor function 23.7 ± 22.1 20 0–80 20.1 ± 15.5 20 0–60 0.341
Psychiatric NMS Depression 8.4 ± 14.8∗∗∗ 0 0–60 34.3 ± 30.6∗ 30 0–100 <0.001
Anxiety 5.7 ± 11.9∗∗ 0 0–50 27.9 ± 29.1∗∗ 20 0–90 <0.001
Concentration/attention 5.3 ± 9.7∗∗∗ 0 0–40 17.6 ± 23.7 5 0–80 0.001
Fatigue 12.0 ± 18.0∗ 0 0–60 32.0 ± 26.3∗∗ 30 0–90 <0.001
Autonomic NMS Bladder urgency 11.7 ± 18.5∗ 0 0–70 27.8 ± 30.8 20 0–80 0.006
Excessive sweating 13.7 ± 23.6∗ 0 0–70 20.4 ± 30.8 0 0–100 0.047
Dizziness 8.8 ± 17.5∗∗ 0 0–70 18.7 ± 24.5 0 0–80 0.005
Sensory NMS Pain 16.6 ± 22.7 0 0–70 31.1 ± 29.9∗ 30 0–100 0.006
Miscellaneous Dysphagia 3.7 ± 10.2∗∗∗ 0 0–50 5.0 ± 9.8∗∗∗ 0 0–40 0.154
Inner restlessness 18.4 ± 21.2 0 0–70 30.5 ± 31.0∗ 25 0–100 0.017
Mahalanobis distance 9.4 ± 4.2 9.8 2.8–17.4 10.3 ± 4.3 10.6 3.1–19.2 0.392
aDisplayed are the ranges of home diary VAS scores from a total of five self-perceived motor On as well as Off states in each individual as a
measure of motor symptom and NMS severity variability. Higher ranges represent higher variability. The Mahalanobis distance was calculated
as a multidimensional measure of data distribution of all NMS severity ranges within each individual subject. ∗represents P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001 when compared to motor function. bP values are from Wilcoxon test.
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DISCUSSION
Although severity and variability of NMF and
their correlation with motor complications have been
described before [3, 6], there are no reports on intrain-
dividual variability of NMS presentations within
defined motor states. By using a systematic assessment
of key NMS during a series of five motor On and five
Off periods [6], we detected a moderate intraindividual
variability of NMS frequencies and severities between
multiple motor On and Off states, with 13–52% insta-
ble fluctuators for motor On and 24–47% instable
fluctuators for motor Off state. Frequencies of insta-
ble fluctuators were higher for motor Off compared to
motor On states for anxiety, depression and bladder
urgency, but not for other NMS.
The factors influencing intraindividual NMF vari-
ability remain largely enigmatic. Similar to the findings
in group analyses showing no or only weak corre-
lations of NMF with motor function or disease state
and no associations with demographic data [6–9], we
did not detect any associations of intraindividual NMF
instability and demographic or clinical characteristics.
Indeed, normalization of NMS severity to motor func-
tion for each motor On or Off state even increases
NMF variability in the present study. NMF variability
in the present study seems to be largely independent
from circadian influences, since the ratings were per-
formed mainly in the morning and no differences in
the time of rating were detected between the various
motor states. Future studies systematically investigat-
ing the timing of NMS and NMF are thus warranted to
further characterize the circadian rhythm of NMS and
their fluctuations.
Several limitations of the present study need to be
addressed. First, NMS in our study were rated during
self-perceived motor states, hence we cannot exclude
that these motor states were different from investigator-
controlled On and Off states. Nevertheless, this study
reflects highly relevant clinical data on everyday life
of PD patients since self-reported outcomes are more
likely to provide a realistic impression of individual
NMS burden. Second, complete diary datasets were
available from only 38% of patients, most likely due
to diary fatigue or higher stress burden by diary entries
in the older and more advanced patients [10]. Although
we did not detect any relevant differences between
completers and non-completers, our data should be
interpreted only for the younger and less advanced
fluctuating PD population (see Supplementary Table 1.
Third, we confined our report to motor On state with-
out distinguishing between “motor On” and “On with
dyskinesias” [6], since most patients have difficulties
judging their hyperkinetic conditions [11], which are
known to influence at least some NMS, such as, e.g.,
dysphagia [12] and pain [5]. The addition of a caregiver
diary to adequately evaluate motor states might thus be
of additional benefit in future studies. Fourth, we used
the range of VAS values from 5 different time points
as an aggregate value for the intraindividual variability
of NMS. Although the test-retest reliability of VAS is
reported to be high for most symptoms [13–15], we
cannot exclude bias due to limited intra-rater agree-
ment for the severity analyses of some NMS.
Our study reports moderate intraindividual vari-
ability in NMF with respect to defined motor states.
Psychiatric NMF were found to be particularly instable
concerning symptom frequency and severity, partic-
ularly in motor Off states. The variability and thus
unpredictability of NMF might contribute to the huge
impact of NMF on hr-QoL [3, 6]. Further research on
NMFs in PD therefore needs to address NMS on a
longitudinal basis to fully encompass their impact on
hr-Qol and to draw conclusions for necessary treat-
ment adjustments such as continuous dopaminergic
stimulation.
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